Exact Therapeutics AS (OSL:EXTX) Ending Cash Position : kr46.43 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Exact Therapeutics AS Ending Cash Position?

Exact Therapeutics AS's Ending Cash Position for the quarter that ended in Dec. 2023 was kr46.43 Mil.

Exact Therapeutics AS's quarterly Ending Cash Position declined from Dec. 2022 (kr69.39 Mil) to Jun. 2023 (kr39.12 Mil) but then increased from Jun. 2023 (kr39.12 Mil) to Dec. 2023 (kr46.43 Mil).

Exact Therapeutics AS's annual Ending Cash Position declined from Dec. 2021 (kr82.91 Mil) to Dec. 2022 (kr69.39 Mil) and declined from Dec. 2022 (kr69.39 Mil) to Dec. 2023 (kr46.43 Mil).

Exact Therapeutics AS Ending Cash Position Historical Data

The historical data trend for Exact Therapeutics AS's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exact Therapeutics AS Ending Cash Position Chart

Exact Therapeutics AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

23.76

139.22

82.91

69.39

46.43

Exact Therapeutics AS Semi-Annual Data
	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial						82.91	78.81	69.39	39.12	46.43

Exact Therapeutics AS Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Exact Therapeutics AS's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	69.39	+	-22.959
	=	46.43

Exact Therapeutics AS's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	39.121	+	7.31
	=	46.43

Exact Therapeutics AS Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Exact Therapeutics AS's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Exact Therapeutics AS (OSL:EXTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exact Therapeutics AS (OSL:EXTX) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ostre Aker vei 19, Oslo, NOR, 0581

Website

https://www.exact-tx.com

Exact Therapeutics AS is a clinical-stage biotechnology company. It is developing a technology platform for therapeutic enhancement - Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement that will amplify the clinical utility of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.

Exact Therapeutics AS (OSL:EXTX) Headlines

No Headlines